InvestSMART

Conneqt Health Limited (ASX:CQT)

ALERT: Price-sensitive ASX Announcement for CQT
Current share price for CQT : $0.017 -0.003 (-15%)+
Announcement
Release
21 Jul 2026 4:05PM
Price at Release
$0.020
Full Release
download
Summary
During the June 2026 quarter, CONNEQT Health Limited experienced significant growth across its consumer, enterprise, and research segments. Consumer revenue reached $1.3 million, driven by a 33% increase in sales of the CONNEQT Pulse device and a 71% growth in digital subscriptions. The company also made strides in its Software as a Medical Device strategy by lodging an FDA Pre-Submission for SphygmoCloud. Enterprise revenue expanded with a 70% increase in recurring revenue. A successful $5.5 million Placement was completed to support further commercial expansion. The company maintained a strong focus on expanding its consumer base, enhancing customer engagement, and continuing the development of its cardiovascular intelligence platform.
Key Points
  • Consumer revenue reached a record $1.3m for the June quarter.
  • CONNEQT Pulse sales increased by 33% quarter-on-quarter.
  • Digital subscriptions and in-app purchases grew by 71%.
  • FDA Pre-Submission lodged for SphygmoCloud.
  • Enterprise subscriptions continued to scale, with a 70% increase in recurring revenue.
  • Completed a $5.5m Placement to support commercial expansion.
  • Management focuses on expanding consumer base and enhancing customer engagement.
  • Research generated approximately $0.8m during the quarter.
  • Continued development of the SphygmoCloud platform.
  • Closing cash of $2.6m, with additional funds expected from the Share Purchase Plan.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.